US$2,224.00
Jul 2010
Macular Degeneration (AMD) and Diabetic Retinopathy Pharmaceutical Market 2010-2025
Our new report examines current and future prospects for the age-related macular degeneration (AMD) and diabetic retinopathy (DR) pharmaceutical markets. The global market for AMD and DR drugs exceeded $2.5bn in 2009, with growth from previous years. We predict that the overall market will expand from 2010 onwards. The rising prevalence of AMD and DR is due to aging populations worldwide and other changes. In particular, the world is facing a "diabetes epidemic", with soaring numbers of people with diabetes and related complications, including diabetic retinopathy.
Order Now
|
More Information
|
Tell-a-Friend
US$2,500.00
Apr 2010
United Kingdom Diabetes Care Devices Market Outlook to 2016
GlobalData's medical equipment offering “United Kingdom Diabetes Care Devices Market Outlook to 2016” provides key market data on the United Kingdom diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
Order Now |
More Information |
Tell-a-Friend
US$2,500.00
Apr 2010
Canada Diabetes Care Devices Market Outlook to 2016
GlobalData’s medical equipment offering, “Canada Diabetes Care Devices Market Outlook to 2016” provides key market data on the Canada diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
Order Now |
More Information |
Tell-a-Friend
US$2,500.00
Apr 2010
Germany Diabetes Care Devices Market Outlook to 2016
GlobalData’s medical equipment offering, “Germany Diabetes Care Devices Market Outlook to 2016” provides key market data on the Germany diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
Order Now |
More Information |
Tell-a-Friend
US$2,500.00
Apr 2010
France Diabetes Care Devices Market Outlook to 2016
GlobalData’s medical equipment offering, “France Diabetes Care Devices Market Outlook to 2016” provides key market data on the France diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
Order Now |
More Information |
Tell-a-Friend
US$2,500.00
Apr 2010
Italy Diabetes Care Devices Market Outlook to 2016
GlobalData’s medical equipment offering, “Italy Diabetes Care Devices Market Outlook to 2016” provides key market data on the Italy diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
Order Now |
More Information |
Tell-a-Friend
US$2,500.00
Apr 2010
Australia Diabetes Care Devices Market Outlook to 2016
GlobalData’s medical equipment offering, “Australia Diabetes Care Devices Market Outlook to 2016” provides key market data on the Australia diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
Order Now |
More Information |
Tell-a-Friend
US$2,500.00
Apr 2010
Brazil Diabetes Care Devices Market Outlook to 2016
GlobalData’s medical equipment offering, “Brazil Diabetes Care Devices Market Outlook to 2016” provides key market data on the Brazil diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
Order Now |
More Information |
Tell-a-Friend
US$2,500.00
Apr 2010
Netherlands Diabetes Care Devices Market Outlook to 2016
GlobalData’s medical equipment offering, “Netherlands Diabetes Care Devices Market Outlook to 2016” provides key market data on the Netherlands diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
Order Now |
More Information |
Tell-a-Friend
US$2,500.00
Apr 2010
Belgium Diabetes Care Devices Market Outlook to 2016
GlobalData’s medical equipment offering, “Belgium Diabetes Care Devices Market Outlook to 2016” provides key market data on the Belgium diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
Order Now |
More Information |
Tell-a-Friend
US$2,500.00
Apr 2010
Mexico Diabetes Care Devices Market Outlook to 2016
GlobalData’s medical equipment offering, “Mexico Diabetes Care Devices Market Outlook to 2016” provides key market data on the Mexico diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
Order Now |
More Information |
Tell-a-Friend
US$2,500.00
Apr 2010
South Africa Diabetes Care Devices Market Outlook to 2016
GlobalData’s medical equipment offering, “South Africa Diabetes Care Devices Market Outlook to 2016” provides key market data on the South Africa diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
Order Now |
More Information |
Tell-a-Friend
US$4,650.00
Apr 2010
BRIC Diabetes Drugs Market
The prevalence of diabetes is on the rise across the globe due to increased life expectancy, changing lifestyles, and the rising incidence of obesity. Brazil’s diabetes drugs market is showing a double digit growth rate; while the Russian insulin market is also expected to witness significant growth with an estimated 20 million patients in the region requiring diabetes treatment by 2025.
Order Now |
More Information |
Tell-a-Friend
US$2,224.00
Mar 2010
World Diabetes Market Analysis 2010-2025
In 2009, the diabetes treatment market generated worldwide sales of over $25 billion, with strong growth from the previous year. The incidence and prevalence of diabetes mellitus are on the rise worldwide, in line with lifestyle changes and ageing populations. In particular, the increasing prevalence of diabetes is closely linked with that of obesity, creating significant market opportunities in developed nations and some developing countries. The World Health Organization estimates the number of diabetics to exceed 350 million by 2030. Governments and other healthcare providers around the world are investing heavily in prevention and treatment of this serious - but controllable - disorder.
Order Now |
More Information |
Tell-a-Friend
US$500.00
Feb 2010
Diabetes Market in UAE
Diabetes is one of the fastest growing lifestyle and debilitating diseases in the Middle East region. At present, one out of every five person in the UAE is suffering from diabetes. The concern becomes a bit serious as diabetes is associated with several other chronic diseases like cardiovascular diseases. This has put an extra burden on the country’s healthcare spending to allocate more funds for diagnosis, care and prevention. According to our new research report “Diabetes Market in UAE” the UAE diabetes care market is projected to grow at a CAGR of more than 8% during 2010-2012.
Order Now |
More Information |
Tell-a-Friend
US$2,995.00
Nov 2009
Anti-Obesity Drugs - Trends and Opportunities Worldwide
The world today is facing an acute crisis of over-weightiness and its more advance form, obesity. The need to combat obesity may be understood from the fact that it gives rise to life threatening ailments such as heart attack, hypertension, diabetes and certain types of cancer. Obesity prevalence translates to wider opportunities for drug companies, as there exists a huge market for highly efficacious and novel anti-obesity drugs. As such, major proportion of currently available drugs does not meet existing requirements for safety profile and efficacy.
Order Now |
More Information |
Tell-a-Friend
US$15,200.00
Oct 2009
Antidiabetics Market Forecast
Datamonitor expects the antidiabetics market to reach $38 billion, across the seven major markets, by 2018. The growth will be driven by the launch of new drug classes, notably the DPP-IV inhibitors and GLP-1 agonists, and large growth in patient numbers. However, patent expiries of the glitazone (TZDs) class will restrain market growth.
Order Now |
More Information |
Tell-a-Friend
US$15,200.00
Oct 2009
Hormonal Contraceptives Market Forecast
Since the 1960s, hormonal contraceptives have been widely used as effective birth control in the developed world. Although they are mainly used to prevent pregnancies, they can be used for treating other conditions such as acne, endometriosis, and polycystic ovarian syndrome. In 2008, the hormonal contraceptives market was worth $6.2 billion across the seven major pharmaceutical countries.
Order Now |
More Information |
Tell-a-Friend
US$3,835.00
Sep 2009
The Diabetes Market Outlook To 2014: Market dynamics, competitive landscape, emerging therapies
Diabetes mellitus is a chronic metabolic disorder that results due to a failure of the body to produce the hormone insulin and/or an inability of the body to respond adequately to circulating insulin. Type 1 diabetes, previously referred to as insulin-dependent diabetes mellitus (IDDM), occurs most commonly in children or young adults and constitutes 5–10% of the diagnosed diabetes patient population. Type 2 diabetes, previously known as adult-onset diabetes or non-insulin-dependent diabetes mellitus (NIDDM), accounts for 90–95% of diagnosed diabetes cases globally and typically develops in middle-aged adults.
Order Now |
More Information |
Tell-a-Friend
US$15,200.00
Jul 2009
Obesity Market Forecast
The obesity market is easily characterized as attractive, featuring a booming patient potential needing long term therapy, but repeated product withdrawals and failed pipeline candidates highlight the reality of increasingly cautious regulatory bodies, reluctant payers, and a clinical community that puts more stock in diet and exercise: $513.7m sales in 2008 fall far short of analyst predictions.
Order Now |
More Information |
Tell-a-Friend
US$1,495.00
Jul 2009
Cachexia - Therapy Area Pipeline Report
Life Science Analytics', Metabolic Endocrinology Cachexia contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of endocrinology drugs by company and by stage as well as a summary of the latest news and developments in this area.
Order Now |
More Information |
Tell-a-Friend
